查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1420964

藥物發現資訊學市場（產品：發現資訊學和開發資訊學；模式：內部資訊學和外包資訊學）- 2023-2031 年全球產業分析、規模、佔有率、成長、趨勢和預測

Drug Discovery Informatics Market (Product: Discovery Informatics and Development Informatics; and Mode: In-house Informatics and Outsourced Informatics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 229 Pages | 商品交期: 2-10個工作天內

價格

藥物發現資訊學市場 - 報告範圍

TMR 關於全球藥物發現資訊學市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球藥物發現資訊學的收入2017- 2031年期間的市場，考慮2023年為基準年，2031年為預測年。報告中也提供了2023年至2031年全球藥物發現資訊學市場的年複合成長率（CAGR %）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解藥物發現資訊學市場。

市場概況
2023年市場價值 27億美元
2031 年市場價值 68 億美元
CAGR 10.9%

該報告深入研究了全球藥物發現資訊學市場的競爭格局。全球藥物發現資訊學市場的主要參與者已經確定，並且每一位參與者都根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球藥物發現資訊學市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2023-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 管道分析
  • 主要產品/品牌分析
  • 主要併購
  • COVID-19 大流行對該行業的影響

第 6 章：全球市場分析與預測：依產品分類

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：按產品，2017-2031
    • 發現資訊學
    • 發展資訊學
  • 市場吸引力：依產品分類

第 7 章：全球市場分析與預測：按模式

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：按模式，2017-2031
    • 內部資訊學
    • 外包資訊學
  • 市場吸引力：按模式

第 8 章：全球市場分析與預測：按功能分類

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依功能分類，2017-2031
    • 定序和目標資料分析
    • 對接
    • 潛在客戶生成資訊學
    • 識別和驗證資訊學
    • 分子模擬
    • 其他
  • 市場吸引力：依功能分類

第 9 章：全球市場分析與預測：按最終用戶

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2017-2031
    • 製藥和生物技術公司
    • 合約研究組織
    • 其他
  • 市場吸引力：按最終用戶分類

第 10 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2017-2031
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力：按地區

第 11 章：北美市場分析與預測

第 12 章：歐洲市場分析與預測

第 13 章：亞太市場分析與預測

第 14 章：拉丁美洲市場分析與預測

第 15 章：中東和非洲市場分析與預測

第16章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2022 年）
  • 公司簡介
    • Charles River Laboratories International, Inc.
    • Thermo Fisher Scientific
    • PerkinElmer Inc.
    • Biogen Inc.
    • Boehringer Ingelheim GmbH
    • Insilico Medicine, Inc.
    • International Business Machines Corporation
    • Schrodinger, LLC
    • Curia Global, Inc.
    • Certara, USA
Product Code: TMRGL33713

Drug Discovery Informatics Market - Scope of Report

TMR's report on the global drug discovery informatics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global drug discovery informatics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global drug discovery informatics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the drug discovery informatics market.

Market Snapshot
Market Value in 2023US$ 2.7 Bn
Market Value in 2031US$ 6.8 Bn
CAGR10.9%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global drug discovery informatics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global drug discovery informatics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global drug discovery informatics market.

The report delves into the competitive landscape of the global drug discovery informatics market. Key players operating in the global drug discovery informatics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global drug discovery informatics market profiled in this report.

Key Questions Answered in Global drug discovery informatics Market Report:

  • What is the sales/revenue generated by drug discovery informatics across all regions during the forecast period?
  • What are the opportunities in the global drug discovery informatics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Drug Discovery Informatics Market - Research Objectives and Research Approach

The comprehensive report on the global drug discovery informatics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global drug discovery informatics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global drug discovery informatics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Drug Discovery Informatics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Drug Discovery Informatics Market Analysis and Forecast, 2023-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Drug Discovery Informatics Market Analysis and Forecast, by Product

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Discovery Informatics
    • 6.3.2. Development Informatics
  • 6.4. Market Attractiveness, by Product

7. Global Drug Discovery Informatics Market Analysis and Forecast, by Mode

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Mode, 2017-2031
    • 7.3.1. In-house Informatics
    • 7.3.2. Outsourced Informatics
  • 7.4. Market Attractiveness, by Mode

8. Global Drug Discovery Informatics Market Analysis and Forecast, by Function

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Function, 2017-2031
    • 8.3.1. Sequencing and Target Data Analysis
    • 8.3.2. Docking
    • 8.3.3. Lead Generation Informatics
    • 8.3.4. Identification and Validation Informatics
    • 8.3.5. Molecular Modeling
    • 8.3.6. Others
  • 8.4. Market Attractiveness, by Function

9. Global Drug Discovery Informatics Market Analysis and Forecast, by End-user

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Pharmaceutical and Biotechnology Companies
    • 9.3.2. Contract Research Organizations
    • 9.3.3. Others
  • 9.4. Market Attractiveness, by End-user

10. Global Drug Discovery Informatics Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America Drug Discovery Informatics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Discovery Informatics
    • 11.2.2. Development Informatics
  • 11.3. Market Attractiveness, by Product
  • 11.4. Market Value Forecast, by Mode, 2017-2031
    • 11.4.1. In-house Informatics
    • 11.4.2. Outsourced Informatics
  • 11.5. Market Attractiveness, by Mode
  • 11.6. Market Value Forecast, by Function, 2017-2031
    • 11.6.1. Sequencing and Target Data Analysis
    • 11.6.2. Docking
    • 11.6.3. Lead Generation Informatics
    • 11.6.4. Identification and Validation Informatics
    • 11.6.5. Molecular Modeling
    • 11.6.6. Others
  • 11.7. Market Attractiveness, by Function
  • 11.8. Market Value Forecast, by End-user
    • 11.8.1. Pharmaceutical and Biotechnology Companies
    • 11.8.2. Contract Research Organizations
    • 11.8.3. Others
  • 11.9. Market Attractiveness, by End-user
  • 11.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Product
    • 11.11.2. By Mode
    • 11.11.3. By Function
    • 11.11.4. By End-user
    • 11.11.5. By Country

12. Europe Drug Discovery Informatics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Discovery Informatics
    • 12.2.2. Development Informatics
  • 12.3. Market Attractiveness, by Product
  • 12.4. Market Value Forecast, by Mode, 2017-2031
    • 12.4.1. In-house Informatics
    • 12.4.2. Outsourced Informatics
  • 12.5. Market Attractiveness, by Mode
  • 12.6. Market Value Forecast, by Function, 2017-2031
    • 12.6.1. Sequencing and Target Data Analysis
    • 12.6.2. Docking
    • 12.6.3. Lead Generation Informatics
    • 12.6.4. Identification and Validation Informatics
    • 12.6.5. Molecular Modeling
    • 12.6.6. Others
  • 12.7. Market Attractiveness, by Function
  • 12.8. Market Value Forecast, by End-user, 2017-2031
    • 12.8.1. Pharmaceutical and Biotechnology Companies
    • 12.8.2. Contract Research Organizations
    • 12.8.3. Others
  • 12.9. Market Attractiveness, by End-user
  • 12.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Product
    • 12.11.2. By Mode
    • 12.11.3. By Function
    • 12.11.4. By End-user
    • 12.11.5. By Country/Sub-region

13. Asia Pacific Drug Discovery Informatics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Discovery Informatics
    • 13.2.2. Development Informatics
  • 13.3. Market Attractiveness, by Product
  • 13.4. Market Value Forecast, by Mode, 2017-2031
    • 13.4.1. In-house Informatics
    • 13.4.2. Outsourced Informatics
  • 13.5. Market Attractiveness, by Mode
  • 13.6. Market Value Forecast, by Function, 2017-2031
    • 13.6.1. Sequencing and Target Data Analysis
    • 13.6.2. Docking
    • 13.6.3. Lead Generation Informatics
    • 13.6.4. Identification and Validation Informatics
    • 13.6.5. Molecular Modeling
    • 13.6.6. Others
  • 13.7. Market Attractiveness, by Function
  • 13.8. Market Value Forecast, by End-user, 2017-2031
    • 13.8.1. Pharmaceutical and Biotechnology Companies
    • 13.8.2. Contract Research Organizations
    • 13.8.3. Others
  • 13.9. Market Attractiveness, by End-user
  • 13.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Product
    • 13.11.2. By Mode
    • 13.11.3. By Function
    • 13.11.4. By End-user
    • 13.11.5. By Country/Sub-region

14. Latin America Drug Discovery Informatics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2017-2031
    • 14.2.1. Discovery Informatics
    • 14.2.2. Development Informatics
  • 14.3. Market Attractiveness, by Product
  • 14.4. Market Value Forecast, by Mode, 2017-2031
    • 14.4.1. In-house Informatics
    • 14.4.2. Outsourced Informatics
  • 14.5. Market Attractiveness, by Mode
  • 14.6. Market Value Forecast, by Function, 2017-2031
    • 14.6.1. Sequencing and Target Data Analysis
    • 14.6.2. Docking
    • 14.6.3. Lead Generation Informatics
    • 14.6.4. Identification and Validation Informatics
    • 14.6.5. Molecular Modeling
    • 14.6.6. Others
  • 14.7. Market Attractiveness, by Function
  • 14.8. Market Value Forecast, by End-user, 2017-2031
    • 14.8.1. Pharmaceutical and Biotechnology Companies
    • 14.8.2. Contract Research Organizations
    • 14.8.3. Others
  • 14.9. Market Attractiveness, by End-user
  • 14.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Product
    • 14.11.2. By Mode
    • 14.11.3. By Function
    • 14.11.4. By End-user
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa Drug Discovery Informatics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product, 2017-2031
    • 15.2.1. Discovery Informatics
    • 15.2.2. Development Informatics
  • 15.3. Market Attractiveness, by Product
  • 15.4. Market Value Forecast, by Mode, 2017-2031
    • 15.4.1. In-house Informatics
    • 15.4.2. Outsourced Informatics
  • 15.5. Market Attractiveness, by Mode
  • 15.6. Market Value Forecast, by Function, 2017-2031
    • 15.6.1. Sequencing and Target Data Analysis
    • 15.6.2. Docking
    • 15.6.3. Lead Generation Informatics
    • 15.6.4. Identification and Validation Informatics
    • 15.6.5. Molecular Modeling
    • 15.6.6. Others
  • 15.7. Market Attractiveness, by Function
  • 15.8. Market Value Forecast, by End-user, 2017-2031
    • 15.8.1. Pharmaceutical and Biotechnology Companies
    • 15.8.2. Contract Research Organizations
    • 15.8.3. Others
  • 15.9. Market Attractiveness, by End-user
  • 15.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Product
    • 15.11.2. By Mode
    • 15.11.3. By Function
    • 15.11.4. By End-user
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. Charles River Laboratories International, Inc.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Thermo Fisher Scientific
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. PerkinElmer Inc.
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Biogen Inc.
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Boehringer Ingelheim GmbH
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Insilico Medicine, Inc.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. International Business Machines Corporation
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Schrodinger, LLC
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Curia Global, Inc.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Certara, USA
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Mode, 2017-2031
  • Table 03: Global Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Function, 2017-2031
  • Table 04: Global Drug Discovery Informatics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 08: North America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Mode, 2017-2031
  • Table 09: North America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Function, 2017-2031
  • Table 10: North America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 13: Europe Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Mode, 2017-2031
  • Table 14: Europe Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Function, 2017-2031
  • Table 15: Europe Drug Discovery Informatics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 18: Asia Pacific Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Mode, 2017-2031
  • Table 19: Asia Pacific Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Function, 2017-2031
  • Table 20: Asia Pacific Drug Discovery Informatics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 23: Latin America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Mode, 2017-2031
  • Table 24: Latin America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Function, 2017-2031
  • Table 25: Latin America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 28: Middle East & Africa Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Mode, 2017-2031
  • Table 29: Middle East & Africa Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Function, 2017-2031
  • Table 30: Middle East & Africa Drug Discovery Informatics Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Drug Discovery Informatics Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031
  • Figure 02: Global Drug Discovery Informatics Market Revenue (US$ Mn), by Product, 2022
  • Figure 03: Global Drug Discovery Informatics Market Value Share, by Product, 2022
  • Figure 04: Global Drug Discovery Informatics Market Revenue (US$ Mn), by Mode, 2022
  • Figure 05: Global Drug Discovery Informatics Market Value Share, by Mode, 2022
  • Figure 06: Global Drug Discovery Informatics Market Revenue (US$ Mn), by Function, 2022
  • Figure 07: Global Drug Discovery Informatics Market Value Share, by Function, 2022
  • Figure 08: Global Drug Discovery Informatics Market Value Share, by End-user, 2022
  • Figure 09: Global Drug Discovery Informatics Market Value Share, by End-user, 2022
  • Figure 10: Global Drug Discovery Informatics Market Value Share, by Region, 2022
  • Figure 11: Global Drug Discovery Informatics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 12: Global Drug Discovery Informatics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 13: Global Drug Discovery Informatics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 14: Global Drug Discovery Informatics Market Value Share Analysis, by Mode, 2022 and 2031
  • Figure 15: Global Drug Discovery Informatics Market Attractiveness Analysis, by Mode, 2023-2031
  • Figure 16: Global Drug Discovery Informatics Market Value Share Analysis, by Function, 2022 and 2031
  • Figure 17: Global Drug Discovery Informatics Market Attractiveness Analysis, by Function, 2023-2031
  • Figure 18: Global Drug Discovery Informatics Market Revenue (US$ Mn), by End-user, 2022
  • Figure 19: Global Drug Discovery Informatics Market Value Share, by End-user, 2022
  • Figure 20: Global Drug Discovery Informatics Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 21: Global Drug Discovery Informatics Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 22: North America Drug Discovery Informatics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 23: North America Drug Discovery Informatics Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 24: North America Drug Discovery Informatics Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 25: North America Drug Discovery Informatics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 26: North America Drug Discovery Informatics Market Value Share Analysis, by Mode, 2022 and 2031
  • Figure 27: North America Drug Discovery Informatics Market Value Share Analysis, by Function, 2022 and 2031
  • Figure 28: North America Drug Discovery Informatics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 29: North America Drug Discovery Informatics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 30: North America Drug Discovery Informatics Market Attractiveness Analysis, by Mode, 2023-2031
  • Figure 31: North America Drug Discovery Informatics Market Attractiveness Analysis, by Function, 2023-2031
  • Figure 32: North America Drug Discovery Informatics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 33: Europe Drug Discovery Informatics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 34: Europe Drug Discovery Informatics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 35: Europe Drug Discovery Informatics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 36: Europe Drug Discovery Informatics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 37: Europe Drug Discovery Informatics Market Value Share Analysis, by Mode, 2022 and 2031
  • Figure 38: Europe Drug Discovery Informatics Market Value Share Analysis, by Function, 2022 and 2031
  • Figure 39: Europe Drug Discovery Informatics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 40: Europe Drug Discovery Informatics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 41: Europe Drug Discovery Informatics Market Attractiveness Analysis, by Mode, 2023-2031
  • Figure 42: Europe Drug Discovery Informatics Market Attractiveness Analysis, by Function, 2023-2031
  • Figure 43: Europe Drug Discovery Informatics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 44: Asia Pacific Drug Discovery Informatics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 45: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 46: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 47: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 48: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by Mode, 2022 and 2031
  • Figure 49: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by Function, 2022 and 2031
  • Figure 50: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 51: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by Product, 2017-2031
  • Figure 52: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by Mode, 2023-2031
  • Figure 53: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by Function, 2023-2031
  • Figure 54: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 55: Latin America Drug Discovery Informatics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 56: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 57: Latin America Drug Discovery Informatics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 58: Latin America Drug Discovery Informatics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 59: Latin America Drug Discovery Informatics Market Value Share Analysis, by Mode, 2022 and 2031
  • Figure 60: Latin America Drug Discovery Informatics Market Value Share Analysis, by Function, 2022 and 2031
  • Figure 61: Latin America Drug Discovery Informatics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 62: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 63: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by Mode, 2023-2031
  • Figure 64: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by Function, 2023-2031
  • Figure 65: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 66: Middle East & Africa Drug Discovery Informatics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 67: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 68: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 69: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 70: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by Mode, 2022 and 2031
  • Figure 71: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by Function, 2022 and 2031
  • Figure 72: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 73: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 74: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by Mode, 2023-2031
  • Figure 75: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by Function, 2023-2031
  • Figure 76: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by End-user, 2023-2031